ISSN 2996-8968
Vol. 9, Issue 1, 2018March 24, 2018 EDT
PEGylated Recombinant Human Hyaluronidase (PEGPH20): transition from a novel functional excipient to an API to increase the chemotherapeutic effectiveness against hyaluronan-rich cancers.
PEGylated Recombinant Human Hyaluronidase (PEGPH20): transition from a novel functional excipient to an API to increase the chemotherapeutic effectiveness against hyaluronan-rich cancers.
apte, shireesh. 2018. “PEGylated Recombinant Human Hyaluronidase (PEGPH20): Transition from a Novel Functional Excipient to an API to Increase the Chemotherapeutic Effectiveness against Hyaluronan-Rich Cancers.” International Journal of Pharmaceutical Excipients 9 (1).